2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $9.4B | $11B | $9.5B | $8.1B | $7.6B |
Cost of Revenue | $6.3B | $7.3B | $6.6B | $5.7B | $5B |
Gross Profit | $3.1B | $3.3B | $2.8B | $2.4B | $2.5B |
Gross Profit % | 33% | 31% | 30% | 30% | 34% |
R&D Expenses | $144M | $153M | $140M | $117M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$770M | $572M | $197M | -$388M | -$216M |
Dep. & Amort. | $357M | $325M | $296M | $334M | $323M |
Def. Tax | -$277M | -$41M | $97M | -$283M | -$114M |
Stock Comp. | $41M | $52M | $12M | $50M | $74M |
Chg. in WC | $495M | -$83M | -$1.2B | $783M | $79M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $981M | $440M | $287M | $332M | $198M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $981M | $440M | $287M | $332M | $198M |
Receivables | $1.7B | $1.5B | $1.3B | $1.2B | $878M |
Inventory | $1.6B | $2B | $2.2B | $1.5B | $1.4B |
Q1 2025 results were in line or ahead of expectations, with core sales at -2.1% (improved sequentially and YoY), normalized gross margin up 150 bps to 32.5% (seventh consecutive quarter of improvement), and normalized operating margin and EPS exceeding guidance.
Newell is maintaining its 2025 net sales guidance (-4% to -2%), normalized operating margin (9% to 9.5%), and normalized diluted EPS ($0.70 to $0.76, up 18% YoY at midpoint), despite moderating core sales outlook to -3% to -1% due to more cautious category growth assumptions.
The company has significantly reduced its China sourcing exposure (from 35% of COGS in 2018 to 15% in 2024, targeting 10% by end of 2025), and is leveraging its robust US and USMCA-compliant manufacturing base to offset tariff impacts and pursue incremental sales opportunities in tariff-advantaged categories.
Newell has fully offset the impact of all "bucket one" tariffs (including initial China, steel/aluminum, and reciprocal tariffs) through cost savings, procurement actions, FX benefits, and targeted pricing; the incremental 125% China tariff is excluded from guidance but could reduce 2025 EPS by up to $0.10 after mitigation, mainly impacting the baby gear category.
The company is actively engaging with retailers to replace private label and competitor products (often China-sourced) with Newell's US/Mexico-made brands, already securing wins in food storage and vacuum sealing; further upside is possible from ongoing discussions in 17 additional categories not yet included in guidance.